OSI Pharmaceuticals

Contact
osip.com
+1631962-2000

OSI Pharmaceuticals, Inc.

41 Pinelawn Road
11747 Melville
USA
+1631962-2000
osip.com
Contact
Profile News
Contact

About OSI Pharmaceuticals

Read more about OSI Pharmaceuticals
Facts about OSI Pharmaceuticals
  • Industry : Pharma

News about OSI Pharmaceuticals

OSI Pharmaceuticals

30-Jan-2009 | business & finance

Dako announces a collaboration with OSI Pharmaceuticals, Inc. on Companion Diagnostics

Dako has entered into a collaboration with OSI Pharmaceuticals, Inc. Under the terms of agreement, Dako and OSI Pharmaceuticals, Inc. will collaborate on ...

Read news
OSI Pharmaceuticals

11-Mar-2008 | business & finance

Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response

Abbott's FISH Technology Provides Analytical Tool with Potential to Assess Clinical Response to Lung Cancer Treatment in Patients with Non-Small-Cell Lung Cancer

Read news
OSI Pharmaceuticals

22-Aug-2007 | business & finance

Dako enters new collaboration on targeted therapies for non-small cell lung cancer

Dako has entered into collaboration with Genentech, OSI and Roche for the clinical development and application for a Premarket Approval Supplement (sPMA) ...

Read news
OSI Pharmaceuticals

01-Aug-2006 | research and development

OSI Pharmaceuticals: Roche Has Received Negative CHMP Opinion in European Union on Tarceva(R) in Pancreatic Cancer

OSI Pharmaceuticals, Inc. announced that Roche, its international partner for Tarceva(R) (erlotinib), received a negative opinion from the European ...

Read news
OSI Pharmaceuticals

19-Apr-2006 | research and development

OSI Pharmaceuticals Announces Submission of New Drug Application for Tarceva(R) in Japan

OSI Pharmaceuticals, Inc. announced that a New Drug Application has been submitted in Japan covering the use of its flagship product, Tarceva(R) (erlotinib ...

Read news
OSI Pharmaceuticals

23-Aug-2005 | business & finance

OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement

OSI Pharmaceuticals, Inc. and Eyetech Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement whereby OSI has agreed to ...

Read news
OSI Pharmaceuticals

20-Apr-2005 | business & finance

OSI Pharmaceuticals Announces Acquisition of All Minority Interest Shares of Prosidion Limited

OSI Pharmaceuticals, Inc. announced that it has completed a stock-for-stock exchange resulting in the acquisition of all minority interest shares of the ...

Read news
Show more news about OSI Pharmaceuticals

Here you will find OSI Pharmaceuticals, Inc.